Multicentre, retrospective analysis on feasibility, delivery and efficacy of MATRix induction regimen in patients with newly diagnosed PCNSL in a real world setting.
dc.contributor.author | Martinez-Calle, N | |
dc.contributor.author | Kell, M | |
dc.contributor.author | Gibb, A | |
dc.contributor.author | Cummin, T | |
dc.contributor.author | Kassam, S | |
dc.contributor.author | Fabbri, A | |
dc.contributor.author | Calimeri, T | |
dc.contributor.author | Ambrosetti, A | |
dc.contributor.author | Orsucci, L | |
dc.contributor.author | Yallop, D | |
dc.contributor.author | Smith, J | |
dc.contributor.author | Linton, Kim M | |
dc.contributor.author | Holl, H | |
dc.contributor.author | Davies, A | |
dc.contributor.author | Kasenda, B | |
dc.contributor.author | Schorb, E | |
dc.contributor.author | Illerhaus, G | |
dc.contributor.author | Cwynarski, K | |
dc.contributor.author | Fox, C | |
dc.date.accessioned | 2018-06-28T19:28:37Z | |
dc.date.available | 2018-06-28T19:28:37Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Multicentre, retrospective analysis on feasibility, delivery and efficacy of MATRix induction regimen in patients with newly diagnosed PCNSL in a real world setting. 2018, 181: 80-80 BR J Haematol | en |
dc.identifier.uri | http://hdl.handle.net/10541/621065 | |
dc.description | Lymphoma Research Team | en |
dc.language.iso | en | en |
dc.title | Multicentre, retrospective analysis on feasibility, delivery and efficacy of MATRix induction regimen in patients with newly diagnosed PCNSL in a real world setting. | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Haematology Department, Nottingham University Hospitals NHS Trust, Nottingham | en |
dc.identifier.journal | British Journal of Haematology | en |